Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2011-09-07 | VRP700 | chronic intractable cough due to underlying lung disease |
Verona Pharma (UK) | Respiratory diseases - Lung diseases | |
2011-09-06 | lexapeptid pegol (NOX-H94) | anemia of chronic diseases as infections, cancers, autoimmune diseases and chronic kidney disease |
1 | Noxxon Pharma (Germany) | Infectious diseases - Hematological diseases - Cancer - Oncology - Autoimmune diseases - Kidney diseases |
2011-09-06 | resminostat (oral pan-histone deacetylase (HDAC) inhibitor) | relapsed/refractory Hodgkin's Lymphoma | 2 | 4SC (Germany) | Cancer - Oncology |
2011-09-06 | AIC316 | genital herpes | 2 | AiCuris (Germany) | Infectious diseases |
2011-09-05 | ICES13 | stress urinary incontinence | 2b | Innovacell (Austria) | |
2011-09-01 | maytansinoid-conjugated human monoclonal antibody against mesothelin (BAY 94-9343 - antibody drug conjugate ADC)) | advanced solid tumors |
1 | Bayer (Germany) | Cancer - Oncology |
2011-08-29 | Solulin (recombinant human thrombomodulin) | hemophilia A | 1b | Paion (Germany) | Hematological diseases - Genetic diseases - Rare diseases |
2011-08-29 | macitentan | idiopathic pulmonary fibrosis | 2 | Actelion (Switzerland) | Respiratory diseases - Lung diseases |
2011-08-23 | PNB01 | major depression disorder (MDD) | 3 | PharmaNeuroBoost (Belgium) | Mental diseases - CNS diseases |
2011-08-23 | somatic cell therapy | advanced peripheral arterial occlusive disease (pAOD) after angioplasty | 1-2 | apceth (Germany) | Cardiovascular diseases |
2011-08-23 | Sym004 | metastatic squamous cell carcinoma of the head and neck |
2 | Symphogen (Denmark) | Cancer Oncology |
2011-08-17 | RPL554 | mild asthma | Verona Pharma (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases | |
2011-08-17 | RPL554 | mild asthma | Verona Pharma (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases | |
2011-08-17 | KUR-023 | adjunction to normal closure techniques such as suturing | Kuros (Switzerland) | ||
2011-08-16 | COR-1 | heart failure, dilated cardiomyopathy (DCM) | 2 | Corimmune (Germany), Cluster m4 personalised medicine and targeted therapies (Germany) | Cardiovascular diseases |
2011-08-15 | IPX066 (investigational carbidopa-levodopa (CD-LD) product with an enhanced pharmacokinetic profile) | Parkinson’s disease |
3 | GSK (UK) Impax Pharmaceuticals (USA - CA) | Neurodegenerative diseases - CNS diseases |
2011-08-05 | ofatumumab | diffuse large B-cell lymphoma | 2 | Genmab (Denmark) | Cancer Oncology |
2011-08-04 | lebrikizumab | asthma | 2 | Roche (Switzerland) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
2011-08-03 | colon cancer screening tests | colorectal advanced adenomatous polyps | MDX Health (Belgium) Exact Sciences (USA) | Cancer Oncology | |
2011-08-02 | ponesimod | relapsing-remitting multiple sclerosis | 2b | Actelion (Switzerland) | Autoimmune diseases - Neurodegenerative diseases |